CBT-based psychoeducation improves anger control and death anxiety in cancer patients receiving chemotherapy

This randomized controlled trial involved 80 individuals receiving chemotherapy, divided into 40 for the control group and 40 for the experimental group. The intervention consisted of eight sessions of CBT-based psychoeducation, while the comparator was a standard control group. The setting and publication type were not reported in the available data.

The primary outcomes assessed were anger control and death anxiety. Results indicated that the gap between pretest and posttest scores was statistically significant for both measures, with p-values less than .05. The direction of change was improvement for both the anger scale total scores and the death anxiety scale total scores.

No absolute numbers or effect sizes were reported for the outcomes. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. The follow-up period was also not reported. Funding or conflicts of interest were not reported.

The practice relevance suggests that CBT-based psychoeducation can be recommended as a professional psycho-oncology practice to improve anger and anxiety in individuals with cancer. However, the lack of reported effect sizes and safety data limits the ability to fully assess the intervention's clinical utility.